IJCS | Volume 33, Nº4, July and August 2020

428 found in familial cases of 22q11.2 deletion syndrome. Am J Med Genet A.2005;136(1):71-5. 10. Maynard TM, Haskell GT, Lieberman JA, LaMantia AS. 22q11 DS: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome. Int J Dev Neurosci. 2002; 20(3-5):407–19. 11. McDonald-McGinn D M, Sullivan KE, Marino B, Philip N, zackai E, Emanuel BS, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers; 2015;1:150-71. 12. Bassett A S, McDonald-McGinn D M, Devriendt K, Digilio M C, Goldenberg P, APractical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332-9. 13. Huber J, Peres V C, de Castro A L, dos Santos T J, da Fontoura Beltrão L. de Baumont A C, et al. Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease. Pediatr Cardiol. 2014;35(8):1356-62. 14. Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R , et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet. 1997;61(3):620-9. 15. Wilson DI, Goodship JA, Burn J, Cross, IE, Scambler PJ. Deletions within chromosome 22q11 in familial congenital heart disease. Lancet. 1992;340(8819):573-5. 16. Matsuoka R, KimuraM, Scambler PJ, MorrowBE, Imamura S, Minoshima S, et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Human Genetics. 1998;103(1):70-80. 17. Demczuk S, Levy A, Aubry M, Croquette M F, Philip N, Prieur M, et al. Excess of deletions of maternal origin in the DiGeorge/velo-cardio-facial syndromes.A study of 22 newpatients and review of the literature. Hum Genet. 1995;96(1):9-13 18. IasconeMR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S. Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet. 2002;108(4):319-21. 19. Leana-Cox J, Pangkanon S, Eanet KR, CurtinMS, Wulfsberg EA. Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature. Am J Med Genet. 1996;65(4):309-16. 20. Conti E, Grifone N, Sarkozy A, Tandoi C, Marino B, Digilio MC, et al. DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene. Eur J Hum Genet . 2003;11(4):349-51. 21. Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/ VCFS or isolated cardiovascular defects. J Med Genet. 2001; 38(12):E45. Santos et al. Congenial heart disease and 22q11 deletion Int J Cardiovasc Sci. 2020; 33(4):423-428 Case Report This is an open-access article distributed under the terms of the Creative Commons Attribution License